BFLY

Butterfly Network Inc
NYSEHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$1.70B
P/E Ratio
—
EPS
$-0.21
Beta
2.12
52W High
$10.21
52W Low
$1.90
50-Day MA
$7.85
200-Day MA
$6.08
Dividend Yield
—
Profit Margin
-43.60%
Forward P/E
—
PEG Ratio
—

About Butterfly Network Inc

Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$123.25M
Gross Profit (TTM)$86.60M
EBITDA$-41.64M
Operating Margin-29.20%
Return on Equity-27.70%
Return on Assets-9.62%
Revenue/Share (TTM)$0.47
Book Value$0.69
Price-to-Book8.80
Price-to-Sales (TTM)13.82
EV/Revenue12.33
EV/EBITDA-9.57
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)51.70%
Shares Outstanding$246.03M
Float$221.25M
% Insiders10.17%
% Institutions62.74%

Historical Volatility

HV 10-Day
131.70%
HV 20-Day
102.09%
HV 30-Day
90.67%
HV 60-Day
89.53%
HV Rank
—

Volatility is currently expanding

Analyst Ratings

Consensus ($11.17 target)
1
Strong Buy
5
Buy

Latest News

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network NYSE: BFLY reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused point-of-care ultrasound operations lifted results.

MarketBeat10/30/2026Neutral
Butterfly Network, Inc. (BFLY) Q3 2026 Earnings Call Transcript

Butterfly Network, Inc. ( BFLY ) Q3 2026 Earnings Call October 29, 2026 8:00 AM EDT Company Participants John Doherty - Executive VP & CFO Joseph DeVivo - CEO, President & Chairman of the Board Conference Call Participants Joshua Jennings - TD Cowen, Research Division William Plovanic - Canaccord Genuity Corp., Research Division David Saxon - Needham & Company, LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Steven Lichtman - William Blair & Company L.L.C., Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ilya Zubkov - Freedom Broker, Research Division Presentation Operator Hello, everyone.

Seeking Alpha10/29/2026Neutral
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

BURLINGTON, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $BFLY #BCI--Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. Bridge was founded with a mission to make BCIs possible without.

Business Wire10/6/2026Neutral
Butterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting.

Business Wire9/8/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BFLY and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026